WO2024142096 - PROCESS FOR PREPARATION OF NIRAPARIB TOSYLATE AND ITS INTERMEDIATES
National phase entry is expected:
Publication Number
WO/2024/142096
Publication Date
04.07.2024
International Application No.
PCT/IN2023/051221
International Filing Date
26.12.2023
Title **
[English]
PROCESS FOR PREPARATION OF NIRAPARIB TOSYLATE AND ITS INTERMEDIATES
[French]
PROCÉDÉ DE PRÉPARATION DE TOSYLATE DE NIRAPARIB ET DE SES INTERMÉDIAIRES
Applicants **
DR. REDDY’S LABORATORIES LIMITED
Inventors
BUDHDEV, Rajeev Rehani
SEKHAR, Nariyam Munaswamy
VARA PRASAD, Vsnvl
NARSIHMA REDDY, Chada
KALANE, Kiran Uttamrao
SARKAR, Soma Rani
BABU, Ireni
Priority Data
202241076686
29.12.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1970 | |
| EPO | Filing, Examination, Granting | 11446 | |
| Japan | Filing, Examination, Granting | 2055 | |
| South Korea | Filing, Examination, Granting | 1850 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
23,861
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present application relates to a process for the preparation Niraparib of formula (II) or its pharmaceutically acceptable salts thereof. The present application also related to novel intermediates of Niraparib. Further, the present application also related to the application of such novel intermediates in the preparation of Niraparib of formula (II) and its tosylate salt of formula (I).[French]
La présente invention concerne un procédé de préparation de niraparib de formule (II) ou de ses sels pharmaceutiquement acceptables. La présente invention concerne également de nouveaux intermédiaires de niraparib. En outre, la présente invention concerne en outre l'application de tels nouveaux intermédiaires dans la préparation de niraparib de formule (II) et de son sel tosylate de formule (I).